Purchase Order 75F40122P00175
Award Date
7/18/22
Potential Completion Date
8/31/23
Potential Value
$87K
Federal Agency
Food and Drug Administration
Ultimate Awardee
Not listed
PSC Category
B537 - Special Studies/Analysis- Medical/Health
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Children's Hospital of Philadelphia (CHOP) has been awarded a Definitive Contract by the Food and Drug Administration (FDA) for $1,048,942.00 to conduct research and development on drug development for pediatric cancers. The contract is a renewal of the FDA's Broad Agency Announcement (BAA) for Advanced Regulatory Science, which seeks proposals across areas of regulatory science to modernize research and support the FDA's mission. The contract has no set-aside designation. As a leading...
The U.S. government agency has awarded a Firm Fixed Price Purchase Order contract to The Children's Hospital of Philadelphia (CHOP) for $20,313.70. The contract, which has no set-aside designation, is for SEQUENCING AND ANALYSIS services, including analysis reference estimates. CHOP, a leading pediatric hospital and research facility, has been awarded this contract to leverage its expertise in areas such as pediatric cancers, rare diseases, genetic disorders, neurodevelopmental conditions, and...
This is a definitive, firm fixed-price contract awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to The Children's Hospital of Philadelphia (CHOP) Research Institute on September 30, 2017 for a value of $322,263.00. The contract does not have a set-aside designation and is for the performance of "OTHER FUNCTIONS" with a completion date of June 30, 2019. CHOP is a pediatric healthcare provider, research institution, and...
This is a federal contract award to The Children's Hospital of Philadelphia (CHOP) from the National Institute of Diabetes and Digestive and Kidney Diseases, a civilian agency within the Department of Health and Human Services. The $18,779,641.25 definitive contract is for research and development facilities, with a period of performance ending on March 31, 2010. The contract does not have a set-aside designation. CHOP, a leading pediatric hospital and research facility, is the prime...
This is a $276,916.98 federal contract awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services, to The Children's Hospital of Philadelphia (CHOP) Research Institute. The contract, which is a definitive contract with cost-no-fee pricing, is for the National Children's Study. The contract does not have a set-aside designation. As a leading pediatric hospital and research institution, CHOP leverages...
This is a definitive contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) Pittsburgh to The Children's Hospital of Philadelphia (CHOP) on September 30, 2019 with a potential value of $374,894.00. The contract, which does not have a set-aside designation, is for research services to be completed by December 27, 2022. CHOP, a non-profit pediatric hospital and research institute, has a history of providing research services to federal...
This is a $135,193.73 firm fixed price purchase order contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to The Children's Hospital of Philadelphia (CHOP). The contract, which does not have a set-aside designation, is for research services related to pediatric diseases and conditions, including genetic diseases, pediatric cancer, and mitochondrial disorders. CHOP, a nonprofit pediatric hospital and research center, has provided research...
The U.S. government has awarded a $34,461 firm fixed-price purchase order contract to The Children's Hospital of Philadelphia (CHOP) for the collection and analysis of the human microbiome. This contract, which does not have a set-aside designation, was awarded on December 10, 2019 by the Office of Logistics and Acquisition Operations, a civilian agency, and has an ultimate completion date of March 27, 2025. CHOP, a leading pediatric hospital and research facility, has significant expertise in...
This is a Firm Fixed Price definitive contract awarded by the Office of the Assistant Secretary for Administration, a civilian agency, to The Children's Hospital of Philadelphia (CHOP) Research Institute. The contract has a ceiling value of $99,455.90 and an ultimate completion date of January 25, 2018. The contract was not set aside. CHOP is a leading pediatric hospital and research facility that provides clinical care, conducts research, and trains future leaders in child health. Through...
The U.S. Food and Drug Administration (FDA) awarded a $692,799.00 definitive contract to The Children's Hospital of Philadelphia Research Institute (CHOP) to acquire professional services to complete the clinical and analytical components of the Pharmacokinetic "Polyethylene Glycol Safety in Children" study. This is a cost-no-fee contract with a period of performance through June 30, 2025. The contract has no set-aside designation. As a leading pediatric research institution, CHOP...